Carole Federico

Carole Federico completed an MSc in Bioethics, followed by a PhD in Experimental Medicine at McGill University. Her dissertation, supervised by Jonathan Kimmelman, applied meta-analytic techniques to understand inefficiencies in the clinical translation of pain drugs. Carole's research focuses on rigor and reproducibility in biomedical science, with a special interest in the conditions of ethical animal research and how preclinical findings affect uncertainty at the transition between preclinical and clinical testing. At Stanford her work is supported by the National Human Genome Research Institute’s Ethical Legal and Social Implications (ELSI) Program.